Enliven Therapeutics, Inc. (ELVN)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
53. 20
+2.34
+4.6009%
$
3.7B Market Cap
- P/E Ratio
- Div Yield
818,000 Volume
-2.36 Eps
$ 50.86
Previous Close 
Want to track ELVN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Enliven Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| WJ William Jones TEMA ETFs LLC | 43,056 | $1.69M | $2.26M | $573,536.26 | 33.98% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 1,333 | $32,117.02 | $69,842.53 | $37,725.51 | 117.46% |
